Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. - Wikidata - wikimedia - TriplyDB

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.

http://www.wikidata.org/entity/Q42435230

about

Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo The Laminin 511/521 binding site on the Lutheran blood group glycoprotein is located at the flexible junction of Ig domains 2 and 3 Biomarkers and recent advances in the management and therapy of sickle cell disease Direct interaction between the Lu/B-CAM adhesion glycoproteins and erythroid spectrin The Lutheran glycoprotein: a multifunctional adhesion receptor Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.Heterogeneous red blood cell adhesion and deformability in sickle cell disease.Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.An antibody to the lutheran glycoprotein (Lu) recognizing the LU4 blood type variant inhibits cell adhesion to laminin α5 Sickle cell disease: selected aspects of pathophysiology.Malaria, erythrocytic infection, and anemia.Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease Sickle red cell-endothelium interactions.Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.Redox-dependent impairment of vascular function in sickle cell disease.Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues.Lipid rafts and malaria parasite infection of erythrocytes.Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.Adhesive activity of Lu glycoproteins is regulated by interaction with spectrin Effect of propranolol as antiadhesive therapy in sickle cell disease.Asthma management in sickle cell disease Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.Pathophysiological insights in sickle cell disease.Emerging drugs for sickle cell anemia.Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease.The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Computational Biomechanics of Human Red Blood Cells in Hematological Disorders.Biomechanics and biorheology of red blood cells in sickle cell anemia.Novel role for the Lu/BCAM-spectrin interaction in actin cytoskeleton reorganization.Protein kinase A-dependent phosphorylation of Lutheran/basal cell adhesion molecule glycoprotein regulates cell adhesion to laminin alpha5.Pathophisiology of sickle cell disease and new drugs for the treatment.Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane The LG1-3 tandem of laminin alpha5 harbors the binding sites of Lutheran/basal cell adhesion molecule and alpha3beta1/alpha6beta1 integrins.

P2860

Q27303155-A86AEBEA-5324-4BA3-A2A1-B13514549740 Q27335195-2CBE4FC7-1F88-4749-804A-A2D8527C53BD Q27646805-6DB4AEED-F43E-4703-AB5B-CA7523998D8E Q28082462-8A2AFFE8-4C5C-4653-8446-643C9C0D6678 Q28270531-F156A138-4E0C-4B39-BF96-9DDE80EB8090 Q28305123-61CCE710-5E79-494E-975D-7E91460B0B93 Q30480100-350988F0-D41C-4C2F-92AF-B0703B538655 Q30601237-A8253406-3B8C-4415-B43B-7A8646271565 Q33676406-19ECF8F0-036E-425C-9BCB-BC49EA5CBBDD Q33791764-15F0FD89-2165-4262-8510-F9C58BE71192 Q33829064-1253A07F-03C5-4421-81FE-932AD9A1C9E9 Q33999451-C7BB29D2-F080-41AD-81D8-97CF0B0CD8C4 Q34023071-A5A5CCBA-E855-4DA1-9DC4-962355B31A8A Q34103054-EA14F7CE-DA72-4164-9492-E47FFFFA089D Q34255075-6D865E33-7DBD-4C30-9601-5D2689AE2C90 Q34686539-D0867048-403C-4881-815D-36F2348F463F Q35533604-A85A86BF-EC48-4158-8DEF-646CBFBE7AA9 Q35750346-0D94C725-B2D7-4B11-B774-E834F4C60250 Q36274222-98C077A5-2901-4A17-9E3A-61E68BB43DF6 Q36425140-4B4B18AD-9AA6-49AF-BCE1-ACFC735E57D0 Q36447783-35F38E6A-DBF1-4D84-AAE5-BCCCFBE725A6 Q36596855-298CF2B9-3B6D-4ED5-A89E-3579F3401A3D Q37003567-0A9D0827-FDDA-4B68-906F-745F0FAA35A2 Q37146392-98D5B802-E399-4DA6-B266-CFA6D7902224 Q37346672-3179E9E0-A369-44BE-8025-FB22FAF666B2 Q37370659-D6CAFD55-EF41-47B2-A737-89F78730FAD2 Q37700189-DC513426-B26E-4640-ABFD-9CF5C34CEEA1 Q37956958-7C802517-1430-4ACA-914B-7764CE2A5948 Q38272226-DB942CAF-AEBC-41EF-A384-0D3677E850AD Q38319921-80C10DEA-AB29-4C63-9900-4D1548A30952 Q38653425-0DA090D2-E184-47B9-83EA-B5A48BEA40C9 Q38694191-688820DF-66A9-486F-B196-3A40E05C4A63 Q38804432-F11D9ACB-57CE-4A4F-8B61-D48AEBA3CA54 Q38998761-95E1580C-581E-4303-A3C7-D3679262FDCD Q39017039-1326369F-CC89-45A6-847B-381B08CF6BE2 Q39571325-0AFA15E6-EAC9-48B7-B6F8-3503F6D0F2AD Q40405421-67F51D8D-2E82-4F3F-9BA3-E86F0F4B6291 Q41777376-941EA27F-C9F6-44A5-B099-BF11C0104DA4 Q42503214-CB00AFA6-DDE6-4C1A-A600-85D89C805432 Q42510120-500D3DF0-15E5-415D-A273-C26D592889F8

P2860

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.

http://www.wikidata.org/entity/Q42435230

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Novel epinephrine and cyclic A ...... dent sickle (SS) RBC adhesion.

@en

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle

@nl

type

label

Novel epinephrine and cyclic A ...... dent sickle (SS) RBC adhesion.

@en

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle

@nl

prefLabel

Novel epinephrine and cyclic A ...... dent sickle (SS) RBC adhesion.

@en

Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle

@nl

P1433

Q42435230-9FC4D4D8-400A-401C-94CA-1F341983E1FF

P1476

Q42435230-6C621663-D20A-4FA2-93F6-CDD05645C6C7

P2093

Q42435230-0E8B3B64-9A86-4743-8987-CA4A345D7B7E

Q42435230-202FE1FF-8587-4C08-ADEF-C7472FD90A15

Q42435230-20618FAA-1187-4FBA-86D9-881CD4C955C3

Q42435230-B2A159AF-A318-4F82-AE0B-396F3F1CA3AF

Q42435230-C8C7C4E7-3CB2-4351-B044-5C9E129E0D25

Q42435230-D8AE96BC-9FB2-432D-9A4C-112278D38095

Q42435230-F967795F-9ED9-41E6-8A16-3CCC037FCE75

Q42435230-FD5AF0C8-652F-4E66-ABEF-A6C50F614D1C

P304

Q42435230-CA6F09B5-F343-44F6-88FC-14A74D47F181

P31

Q42435230-FD5F75EC-71C4-42E0-A217-1CD335D70185

P356

Q42435230-E4A8FE6F-2F3C-494D-AA0F-5CAA8349A2D4

P407

Q42435230-1A83A184-5C34-42E1-865C-2F32243F5F3B

P433

Q42435230-F3AF9A35-4964-4932-95DA-99D1C8C002A1

P478

Q42435230-1492AC99-A2ED-41C5-8C41-283BCFD17ABF

P577

Q42435230-AFDC719F-D218-482F-B68A-1CF3AE02A497

P5875

Q42435230-3DEAC1FF-03A7-4253-88BE-DA4C4AD0CEEC

P698

Q42435230-6878C9BB-F601-4EA3-B6D2-9FDC758E13DC

P356

BLOOD-2001-12-0289

P1433

P1476

Novel epinephrine and cyclic A ...... dent sickle (SS) RBC adhesion.

@en

P2093

Deborah A Shea

http://www.w3.org/2001/XMLSchema#string

Eugene P Orringer

http://www.w3.org/2001/XMLSchema#string

Kenneth I Ataga

http://www.w3.org/2001/XMLSchema#string

Leslie V Parise

http://www.w3.org/2001/XMLSchema#string

Marilyn J Telen

http://www.w3.org/2001/XMLSchema#string

Patrick C Hines

http://www.w3.org/2001/XMLSchema#string

Qin Zen

http://www.w3.org/2001/XMLSchema#string

Sharran N Burney

http://www.w3.org/2001/XMLSchema#string

P304

3281-3287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2001-12-0289

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10970075

http://www.w3.org/2001/XMLSchema#string

P698

12506027

http://www.w3.org/2001/XMLSchema#string